>>>Familial Cancer
Familial Cancer2019-02-04T09:17:22+00:00

Familial Cancer

It is estimated that around 5% of all tumors have a hereditary character. The identification of families with hereditary cancer allows the establishment of effective measures not only in the early detection, but also in the prevention of tumors. Likewise, the identification of the genetic origin of a tumor directs the selection of the most suitable treatment and clinical management.

OncoNIM® BRCA Prevent

Study based on massive sequencing directed to the identification of mutations and to the screening of large rearrangements in the BRCA1/2 genes.

The genetic study of the BRCA1 and BRCA2 genes is indicated in:

  • Identification of patients with hereditary breast and ovarian cancer syndrome
  • In the study of ovarian cancer for the selection of patients candidates for treatment with PARP inhibitors.

Depending on the indication, this study is performed in peripheral blood or in tumor samples.

Reference: ONC2006
Delivery of results: 20 working days from receipt of the sample.

Contact us

KaryoNIM® Familial Breast and Ovarian Cancer

Array-CGH 60K platform for the study of amplifications, duplications and deletions associated with hereditary breast and ovarian cancer. High resolution analysis of 7 genes related to these tumors, being able to detect gains and losses of genetic material of at least 1 kb. The remainder of the genome is analyzed with an average resolution of 750 kb.

 
Reference: ONC2001
Delivery of results: 15 working days from receipt of the sample.

Contact us

KaryoNIM® Familial Colon Cancer

Array-CGH 60K platform for the study of amplifications, duplications and deletions associated with familial colon cancer. High resolution analysis of 17 genes related to these tumors, being able to detect gains and losses of genetic material of at least 1 kb. The remainder of the genome is analyzed with an average resolution of 750 kb.

 
Reference: ONC2003
Delivery of results: 15 working days from receipt of sample.

Contact us

KaryoNIM® Familial Endocrine Cancer

Array-CGH 60K for the study of amplifications, duplications and deletions associated with familial ENDOCRINE cancer.
High resolution analysis of 1O genes related to these tumors, being able to detect gains and losses of genetic material of at least 1 kb. The remainder of the genome is analyzed with an average resolution of 750 kb.

Delivery of results: 15 working days from receipt of sample.

Contact us

NIM®Seq Familial Cancer

NIMGenetics makes available to the specialist the sequencing of gene panels for the study of familial or hereditary cancer syndromes.

Contact us

Any doubt about Familiar Cancer?

Send us a message

I accept the privacy policy

Do you prefer that we call you?